Press Releases PreveCeutical Medical Inc.

Equities

CA74141E1043

Delayed Canadian Securities Exchange Other stock markets 09:42:48 2024-06-03 am EDT			5-day change	1st Jan Change
0.025 ^CAD	-16.67%		0.00%	0.00%

May. 02	PreveCeutical Medical Inc. announced that it expects to receive CAD 0.25 million in funding	CI
2023	PreveCeutical Medical Inc. Initiates Preparation of Preclinical Study for Its Diseases & Obtains Proof-Of-Concept Dual Gene Therapy Program	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Preveceutical Provides Update on Management Cease Trade Order	May. 30	NE
Preveceutical Announces First Tranche Closing of Private Placement	May. 29	NE
PreveCeutical Medical : Announces First Tranche Closing of Private Placement	May. 29	PU
PreveCeutical Provides Update on Management Cease Trade Order	May. 16	NE
PreveCeutical Announces Management Cease Trade Order	May. 02	NE
PreveCeutical Medical : Showcases Dynamic Evolution in AI Strategy	23-09-12	PU
PreveCeutical Engages New to the Street for Production and Broadcasting Services	23-09-01	AQ
PreveCeutical Medical : Engages New to the Street for Production & Broadcasting Services	23-08-31	PU
PreveCeutical Medical : Files Cyclic Peptides And Uses Thereof in the EU and Australia	23-07-24	PU
PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use and Cyclic Peptides and Uses Thereof	23-06-29	AQ
PreveCeutical Medical : Files Two Family Patents of Sol-Gel Cannabinoid Formulation And Antiviral Use & Cyclic Peptides And Uses Thereof	23-06-28	PU
PreveCeutical Medical : Sol-Gel and Uses thereof Patent Update	23-05-30	PU
PreveCeutical Medical : Launches Clinical Artificial Intelligence Division	23-04-24	PU
PreveCeutical Medical : Announces Live Interactive Q&A Video Conference	23-04-20	PU
PreveCeutical Medical : Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain	23-04-04	PU
PreveCeutical Initiates Non-Analgesic Program Clinical Development Program and Disclosure Committee	23-03-21	AQ
PreveCeutical Medical : – International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof	23-03-06	PU
Appointment of C. Evan Ballantyne to PreveCeutical's Board of Directors	23-02-22	AQ
PreveCeutical Medical : Appointment of C. Evan Ballantyne to PreveCeutical’s Board of Directors	23-02-21	PU
IIROC Trade Resumption - PREV	23-02-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases PreveCeutical Medical Inc.

Equities

PREV

CA74141E1043

Press Releases

Filters